JCTechnology LLC introduces Clario, a native iOS app that lets users ask anything about their finances in plain English ...

Clario, a leading provider of endpoint data solutions to the clinical trials industry, today announced that its artificial intelligence (AI) management system has been certified to the ISO 42001:2023 ...

In this free webinar, gain insights into selecting and validating digital endpoints in early and mid-phase studies, including what makes an endpoint scientifically robust, feasible and appropriate for ...

More than 20 years ago, Stephen McWhirter was a meth addict and wounded preacher’s kid who had a life-changing encounter with Jesus. Today, he travels the world leading worship and sharing his ...

Alphabet took a chunk out of its massive capital expenditure plan with a blockbuster $20bn trade that tested the willingness of bond investors to support big tech financings.

Thermo Fisher Scientific Inc. ("Thermo Fisher") announced today that it has priced an offering of $3.8 billion aggregate principal amount (the "Offering") of the following notes: $1.0 billion ...

February 10 marks Safer Internet Day, a global prompt for families to think about how children engage with the online space.

In this free webinar, learn how assessing cardiac safety risks of a new oncologic agent in early-phase clinical trials can be achieved with minimal impact on development cost and complexity. Attendees ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

Bengaluru: Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound ...

Thermo Fisher Scientific has agreed to acquire Clario Holdings for nearly $8.9 billion, in a deal that would give it control of a widely used digital toolkit for managing clinical trial data. Clario's ...

Oct 29 (Reuters) - Thermo Fisher (TMO.N), opens new tab said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research ...